Essential complicity of perforin-granzyme and FAS-L mechanisms to achieve tumor rejection following treatment with anti-CD137 mAb

BACKGROUND: Treatment with agonist anti-CD137 (4-1BB) immunostimulatory monoclonal antibodies elicits complete tumor regressions in a number of transplanted hematological and solid malignancies in mice. Rejection is mainly dependent on cytotoxic T lymphocytes (CTL) and IFNγ, although a role for NK c...

Descripción completa

Detalles Bibliográficos
Autores principales: Morales-Kastresana, Aizea, Catalán, Elena, Hervás-Stubbs, Sandra, Palazón, Asis, Azpilikueta, Arantza, Bolaños, Elixabet, Anel, Alberto, Pardo, Julián, Melero, Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987045/
https://www.ncbi.nlm.nih.gov/pubmed/24764534
http://dx.doi.org/10.1186/2051-1426-1-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987045/
https://www.ncbi.nlm.nih.gov/pubmed/24764534
http://dx.doi.org/10.1186/2051-1426-1-3

Ejemplares similares